In the KMF (KRAS, MYC, Focal adhesion kinase (FAK)) synthetic ovarian tumor model, FAK activation regulates the expression of CD155, a checkpoint ligand for T cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domains (TIGIT). Here, PTK2 is linked to ovarian neoplasm.